Xeljanz XR 11 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FNKEJ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,199
Award facts
- Contract value 100% obligated
- $3,198.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $3,198.50 delivery order to AmerisourceBergen Drug Corp for XELJANZ XR 11 MG tablets (30-count units) on August 15, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price contract represents a non-set-aside award made through open competition. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its Corporate Office location. The delivery order falls under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive global pharmaceutical support vehicle valued through December 2026.
AmerisourceBergen Drug Corp serves as a critical vendor for federal medical procurement, supplying a wide range of pharmaceutical products and medical supplies to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive portfolio of federal contract awards demonstrates its capability to meet diverse military healthcare requirements across multiple therapeutic domains. XELJANZ XR is a specialty medication used in the treatment of rheumatoid arthritis and other autoimmune conditions, representing the type of therapeutic pharmaceutical that supports military medical readiness and veteran healthcare needs through the DLA's medical supply chain.
Quick answers
Who was awarded contract SPE2DB25FNKEJ?
SPE2DB25FNKEJ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 15, 2025.
How much is contract SPE2DB25FNKEJ worth?
The government has obligated $3,199 on SPE2DB25FNKEJ.
Is contract SPE2DB25FNKEJ an order under another contract?
Yes. SPE2DB25FNKEJ is a delivery order under SPE2DB20D1004, an indefinite delivery contract.
Was contract SPE2DB25FNKEJ competed?
The extent of competition for SPE2DB25FNKEJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award